ANNE SYMBAS: Open Payments
NPI 1003169509 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 10 payments from 7 companies in 2025. Trend: 2023 $1,175 · 2024 $663 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Botanix SB Inc | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| Lilly USA, LLC | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: COSENTYX, SOFDRA, RINVOQ, EBGLYSS, OPZELURA, TREMFYA, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
